Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  76 results for ""Drug Eruptions""

Your Filters

Geographic : united states Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's Adverse Event Reporting System dataset.

  • Authors : Salah S; La Roche-Posay Laboratoire Dermatologique, Levallois Perret, France. Electronic address: .; Kerob D

Subjects: Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; United States Food and Drug Administration* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Nov; Vol. 91 (5), pp. 863-871. Date of Electronic Publication: 2024 Jul 20.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists.

Subjects: United States Food and Drug Administration*; Humans ; United States/United States/United States/epidemiology

  • Source: Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2024 Sep 01; Vol. 23 (9), pp. e181-e182.Publisher: Physicians Continuing Education Corporation Country of Publication: United States NLM ID: 101160020 Publication Model:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Drug patch testing for severe cutaneous adverse reactions: Not in the United States?

  • Authors : Whitley L; Los Alamos Medical Care Clinic Ltd, Los Alamos, New Mexico; Department of Clinical Medicine, Burrell College of Osteopathic Medicine, Las Cruces, New Mexico.

Subjects: Skin* ; Drug Eruptions*; Humans

  • Source: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2023 May; Vol. 130 (5), pp. 538-539.Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication

Record details

Read More Add to Saved list
×
Academic Journal

Severe cutaneous adverse reactions associated with immune checkpoint inhibitors therapy and anti-VEGF combination therapy: a real-world study of the FDA adverse event reporting system.

  • Authors : Li C; Department of Pharmacy, Qilu Hospital of Shandong University, Jinan, China.; Li Z

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/administration & dosage ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Jun; Vol. 23 (6), pp. 777-784. Date of Electronic Publication: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab Vedotin.

  • Authors : Vlachou E; The Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD.; Mamtani R

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; White People*/White People*/White People*/statistics & numerical data

  • Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Jun; Vol. 22 (3), pp. 102090. Date of Electronic Publication: 2024 Apr 07.Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.

  • Authors : Godfrey H; University of Arizona College of Medicine-Tucson, Tucson, Arizona, USA.; Jedlowski P

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; United States Food and Drug Administration*

  • Source: The Australasian journal of dermatology [Australas J Dermatol] 2024 May; Vol. 65 (3), pp. 243-253. Date of Electronic Publication: 2024 Apr 04.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0135232 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.

  • Authors : Wongvibulsin S; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/drug therapy ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/epidemiology ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Mar; Vol. 86 (3), pp. 563-572. Date of Electronic Publication: 2021 Apr 02.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study.

  • Authors : Boull CL; Division of Pediatric Dermatology, University of Minnesota, Minneapolis, Minnesota.; Gardeen S

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*epidemiology ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Jun; Vol. 84 (6), pp. 1554-1561. Date of Electronic Publication: 2020 Jul 17.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system.

  • Authors : Aggarwal P; a College of Medicine , University of Cincinnati Medical Center , Cincinnati , OH , USA.

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Nivolumab/Nivolumab/Nivolumab/*adverse effects

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2019 Jul; Vol. 18 (7), pp. 623-633. Date of Electronic Publication: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study.

  • Authors : Keller SF; Division of Rheumatology, Allergy and Immunology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.; Lu N

Subjects: Allopurinol/Allopurinol/Allopurinol/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*ethnology ; Gout Suppressants/Gout Suppressants/Gout Suppressants/*adverse effects

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2018 Aug; Vol. 77 (8), pp. 1187-1193. Date of Electronic Publication: 2018 Apr 13.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

Read More Add to Saved list
×
  • 1-10 of  76 results for ""Drug Eruptions""